Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy

JAMA Internal Medicine - United States
doi 10.1001/jamainternmed.2014.1232
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Prediction of Relapse After Discontinuation of Infliximab Therapy in Severe Sarcoidosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Recovery of Trabecular and Cortical Bone Turnover After Discontinuation of Risedronate and Alendronate Therapy in Ovariectomized Rats

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2008English

Alendronate Prevents Loss of Bone Density Associated With Discontinuation of Hormone Replacement Therapy

Archives of Internal Medicine
2003English

Risk of Subsequent Fracture and Mortality Within 5 Years After a Non-Vertebral Fracture

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2010English

Evaluation of Bayesian Classifiers in Asthma Exacerbation Prediction After Medication Discontinuation

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

Meabolic Fate of 4-Amino-1-Hydroxybutylidene-1,1-Bisphosphonate(alendronate). (I). Plasma Concentration, Distribution and Excretion After Intravenous Administration of Alendronate to Rats.

Drug Metabolism and Pharmacokinetics
1995English

Radiological Prediction of Posttraumatic Kyphosis After Thoracolumbar Fracture

The Open Orthopaedics Journal
2016English

Hormone Therapy Discontinuation

Menopause
GynecologyObstetrics
2010English

After 5 Years at Science

Science
MultidisciplinaryPhilosophy of ScienceHistory
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy